10x Genomics Gross margin
What is the Gross margin of 10x Genomics?
The Gross margin of 10x Genomics, Inc. is 66.15%
What is the definition of Gross margin?
Gross margin is the difference between revenue and cost of goods sold, divided by revenue, and expressed as a percentage.
lfy (last fiscal year)
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Gross margin of companies in the Health Care sector on NASDAQ compared to 10x Genomics
What does 10x Genomics do?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Companies with gross margin similar to 10x Genomics
- Shilpa Medicare has Gross margin of 66.08%
- Vocera Communication Inc has Gross margin of 66.08%
- SPS Commerce has Gross margin of 66.09%
- First Property plc has Gross margin of 66.13%
- Solutions 30 SE has Gross margin of 66.14%
- Australian Ethical Investment Ltd has Gross margin of 66.14%
- 10x Genomics has Gross margin of 66.15%
- Western Areas has Gross margin of 66.16%
- RPG Life Sciences has Gross margin of 66.17%
- Chugai Pharmaceutical Co has Gross margin of 66.18%
- Presidio Property Trust has Gross margin of 66.19%
- Dragontail Systems has Gross margin of 66.21%
- Wishpond Technologies has Gross margin of 66.21%